Skip to Content

Press Releases

Latta Supports More Cures, Not Fewer

Washington, December 12, 2019 | Rebecca Card (202.225.6405)

Click HERE to watch Congressman Latta speak on the House floor in support of the bipartisan Lower Costs, More Cures Act. 

Today, Congressman Bob Latta (R-OH5) voted against H.R.3, a partisan bill that would result in fewer cures, would harm innovation, and will never become law. Instead, Congressman Latta voted in support of H.R. 19, the Lower Costs, More Cures Act, a bipartisan plan that would lower the costs of critically needed prescription medications for people across the country, encourage innovation, and could actually be signed into law.

Earlier this week, Congressman Latta penned an op-ed in the Lima News shining a spotlight on how the Lower Costs, More Cures Act is a win for the American people.

As stated in the piece, “Our plan doesn’t crush investment in the research and development of new cures. When confronted with the realities of what H.R. 3 would mean for fewer new drugs, some Democrats have said it is ‘worth it’ to lose new cures in order pass their partisan plan. But, when it comes to drugs that improve or save a loved one’s life, we know it is not ‘worth it.’ Our bipartisan plan stands in stark contrast as it increases low-cost options for patients by bringing more generic and biosimilar competition to the marketplace faster. It puts politics to the side and prioritizes what Americans need most – more cures and better access to affordable medications.”

Click here to read the op-ed online.


Back to top